🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

Phase 2RecruitingNCT05615636

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

👨‍⚕️ Jason Westin, MD, MS, FACP, M.D. Anderson Cancer Center📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT05866783

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

🏥 University Hospital, Ghent📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT06081205

Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease

👨‍⚕️ Lampros K Michalis, MD, PhD, Professor of Cardiology, Director of the 2nd Cardiology Department, University Hospital of Ioannina📍 1 site📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT04919629

APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion

👨‍⚕️ Emese Zsiros, Roswell Park Cancer Institute📍 1 site📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05835687

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

👨‍⚕️ Christopher DeRenzo, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT06729944

Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours

👨‍⚕️ Francesco Vasuri, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT06370065

Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients

🏥 Tianjin Medical University Cancer Institute and Hospital📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT05854433

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

👨‍⚕️ Araya Puwanant, MD, MS, Wake Forest University Health Sciences📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT05839210

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors

👨‍⚕️ Tracy E Crane, Phd, RDN, University of Miami📍 1 site📅 Started Apr 2023View details ↗
Phase 3RecruitingNCT05832580

The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum

🏥 UMC Utrecht📍 1 site📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05512390

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

👨‍⚕️ ABBVIE INC., AbbVie📍 20 sites📅 Started Apr 2023View details ↗
RecruitingNCT04925089

Localized Leiomyosarcoma Biomarker Protocol

👨‍⚕️ Scott Schuetze, University of Michigan Rogal Cancer Center📍 3 sites📅 Started Apr 2023View details ↗
RecruitingNCT05802836

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

👨‍⚕️ Christoph Koenigs, PD Dr. Dr, Goethe University📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT05767762

Evertor Muscle Activity as a Predictor of Achilles Tenotomy in the Management of Idiopathic Varus Equinus Clubfoot

🏥 Fondation Lenval📍 1 site📅 Started Apr 2023View details ↗
Phase 4RecruitingNCT07022496

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

🏥 Ain Shams University📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT05491031

MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis

🏥 Poitiers University Hospital📍 1 site📅 Started Apr 2023View details ↗
Phase 1, PHASE2RecruitingNCT05732103

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

👨‍⚕️ Guillermo Garcia-Manero, MD, M.D. Anderson Cancer Center📍 7 sites📅 Started Apr 2023View details ↗
Phase 1, PHASE2RecruitingNCT05268237

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

👨‍⚕️ Elaine YK Chow, Chinese University of Hong Kong📍 1 site📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05775159

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

🏥 AstraZeneca📍 60 sites📅 Started Apr 2023View details ↗
RecruitingNCT05652101

Hyperekplexia : Adaptative Skills and Neurodevelopmental Trajectory

🏥 Hospices Civils de Lyon📍 1 site📅 Started Apr 2023View details ↗
← PreviousPage 413 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →